Glaxosmithkline Pharmaceuticals to focus on 20 brands, 5 therapeutic segments: Report

16 Jul 2019

GlaxoSmithKline Pharmaceuticals, the Indian unit of British drug major GSK, is reportedly planning to  focus its energies on 20 brands and 5 therapeutic segments anti-infectives, dermatology, respiratory, gastro-intestinal and anti-pyretic to drive future growth in India.

The drug maker is also looking for deeper engagement with distribution channel partners and securing control over the supply chain with its own factories.

GlaxoSmithKline Pharmaceuticals (GSK Rx India) is one of the oldest pharmaceuticals company. The GSK India product portfolio includes prescription medicines and vaccines.

Related Glaxosmithkline Pharmaceuticals Ltd. Links:

Glaxosmithkline Phar Share Price

1524.50 57.40 (3.91%) Mar 03, 18:59
1 Year Price Chart
Company Name CMP
Sun Pharma Inds. 624.15
Dr. Reddys Lab 4500.80
Lupin 1060.85
Piramal Enterprises 1992.70
Cadila Healthcare 445.50
View more..
Sensex vs Glaxosmithkline Phar
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323